| Dr Christopher Mark Hanson, DDS | |
|
1061 E Main St, Suite 3, Grass Valley, CA 95945-5724 | |
| (530) 477-6172 | |
| Not Available |
| Full Name | Dr Christopher Mark Hanson |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 1061 E Main St, Grass Valley, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235393638 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 57130 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Mark Hanson, DDS 1061 E Main St, Suite 3, Grass Valley, CA 95945-5724 Ph: (530) 477-6172 | Dr Christopher Mark Hanson, DDS 1061 E Main St, Suite 3, Grass Valley, CA 95945-5724 Ph: (530) 477-6172 |
News Archive
Studies show 97 percent of American adults get less than 30 minutes of exercise a day, which is the minimum recommended amount based on federal guidelines. New research from the University of Missouri suggests certain genetic traits may predispose people to being more or less motivated to exercise and remain active.
"The $100 billion medical-device industry is scrambling to reverse billions of dollars in fees proposed by the Senate Finance Committee, but it faces trouble because its reluctance to offer concessions alienated some lawmakers," the Wall Street Journal reports.
Federal legislation encouraging the study of drugs in pediatric patients has resulted in very few labeling changes that include new infant information, according to a study by Matthew M. Laughon, M.D., M.P.H., of the University of North Carolina at Chapel Hill, and colleagues.
Bristol-Myers Squibb Company today announced four-year data from the Phase 3 CheckMate -067 clinical trial - the longest follow-up to date - which continues to demonstrate durable, long-term survival benefits with the first-line combination of Opdivo (nivolumab) and Yervoy (ipilimumab), versus Yervoy alone, in patients with advanced melanoma.
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
› Verified 8 days ago
Robert P Giuliani, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1061 E Main St, Suite 202, Grass Valley, CA 95945 Phone: 530-272-4201 Fax: 530-272-4202 | |
Dr. Adriaan Boer, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 622 So Auburn St, Grass Valley, CA 95945 Phone: 530-272-4276 | |
Nathan Charles Brott, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 300 Sierra College Drive, Suite 285, Grass Valley, CA 95945 Phone: 530-272-9400 Fax: 530-272-9404 | |
Ray G Enneking, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 316 S Auburn St Ste 5, Grass Valley, CA 95945 Phone: 530-274-0920 Fax: 530-274-8935 | |
Wendell David Clove, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 152 Catherine Ln, Grass Valley, CA 95945 Phone: 530-273-9111 Fax: 530-274-7937 | |
Dr. Amalia Nichole Griego, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 316 S Auburn St Ste 6, Grass Valley, CA 95945 Phone: 530-272-2692 Fax: 530-272-5387 | |
Dr. Robert Alexander Racine, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 10052 Alta Sierra Dr, Suite B, Grass Valley, CA 95949 Phone: 530-272-6621 Fax: 530-272-9925 |